Follow
David S Ziegler
David S Ziegler
Sydney Children's Hospital
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
Comprehensive analysis of hypermutation in human cancer
BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ...
Cell 171 (5), 1042-1056. e10, 2017
6832017
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
S Shah, KA Schrader, E Waanders, AE Timms, J Vijai, C Miething, ...
Nature genetics 45 (10), 1226-1231, 2013
3382013
Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International …
LM Hoffman, SEMV Van Zanten, N Colditz, J Baugh, B Chaney, ...
Journal of clinical oncology 36 (19), 1963, 2018
3172018
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ...
Nature medicine 26 (11), 1742-1753, 2020
2072020
Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ...
Cancer discovery 10 (7), 942-963, 2020
2032020
Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models
T Hennika, G Hu, NG Olaciregui, KL Barton, A Ehteda, A Chitranjan, ...
PloS one 12 (1), e0169485, 2017
1522017
Frontiers in the treatment of glioblastoma: Past, present and emerging
TI Janjua, P Rewatkar, A Ahmed-Cox, I Saeed, FM Mansfeld, ...
Advanced drug delivery reviews 171, 108-138, 2021
1422021
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
DS Ziegler, RD Wright, S Kesari, ME Lemieux, MA Tran, M Jain, L Zawel, ...
The Journal of clinical investigation 118 (9), 3109-3122, 2008
1342008
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
DR Carter, J Murray, BB Cheung, L Gamble, J Koach, J Tsang, S Sutton, ...
Science translational medicine 7 (312), 312ra176-312ra176, 2015
1302015
Therapeutic targeting of apoptosis pathways in cancer
DS Ziegler, AL Kung
Current Opinion in Oncology 20 (1), 97-103, 2008
1302008
Anti-apoptosis mechanisms in malignant gliomas
DS Ziegler, AL Kung, MW Kieran
Journal of Clinical Oncology 26 (3), 493-500, 2008
1192008
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
W Sun, J Malvar, R Sposto, A Verma, JJ Wilkes, R Dennis, K Heym, ...
Leukemia 32 (11), 2316-2325, 2018
1152018
Brief report: potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
DS Ziegler, M Wong, C Mayoh, A Kumar, M Tsoli, E Mould, V Tyrrell, ...
British Journal of Cancer 119 (6), 693-696, 2018
1142018
Histone H3. 3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis
CCL Chen, S Deshmukh, S Jessa, D Hadjadj, V Lisi, AF Andrade, D Faury, ...
Cell 183 (6), 1617-1633. e22, 2020
1112020
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
LD Gamble, S Purgato, J Murray, L Xiao, DMT Yu, KM Hanssen, ...
Science Translational Medicine 11 (477), eaau1099, 2019
1042019
Too many targets, not enough patients: rethinking neuroblastoma clinical trials
JI Fletcher, DS Ziegler, TN Trahair, GM Marshall, M Haber, MD Norris
Nature Reviews Cancer 18 (6), 389-400, 2018
842018
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
F Doz, CM Van Tilburg, B Geoerger, M Højgaard, I Øra, V Boni, M Capra, ...
Neuro-oncology 24 (6), 997-1007, 2022
832022
Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.
AE Drilon, SG DuBois, AF Farago, B Geoerger, JE Grilley-Olson, DS Hong, ...
Journal of Clinical Oncology 37 (15_suppl), 2006-2006, 2019
822019
Transplant‐related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25‐year retrospective review
MK Mateos, TA O'Brien, C Oswald, M Gabriel, DS Ziegler, RJ Cohn, ...
Pediatric blood & cancer 60 (9), 1520-1527, 2013
812013
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
BK Li, A Vasiljevic, C Dufour, F Yao, BLB Ho, M Lu, EI Hwang, ...
Acta neuropathologica 139, 223-241, 2020
802020
The system can't perform the operation now. Try again later.
Articles 1–20